NASDAQ:CORT

Corcept Therapeutics Stock News

etoro logo Buy CORT
*Your capital is at risk
$72.65
+1.45 (+2.04%)
At Close: Jun 03, 2026
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and succes
Deutsche Bank AG grew its holdings in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT) by 1,325.8% in the 1st quarter, according to the company in its most recent 13F filing with the Securiti
Corcept Therapeutics Incorporated (CORT), a commercial-stage company engaged in the discovery and development of drugs to treat severe metabolic, oncologic and psychiatric disorders by modulating the

7 Great Biotech Stocks to Buy and Hold Now

02:55pm, Thursday, 11'th Jun 2020
As investors begin to turn their attention away from Covid-19 and the novel coronavirus, these biotech stocks present excellent opportunities.
State Street Corp raised its stake in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT) by 4.9% during the 1st quarter, according to the company in its most recent Form 13F filing with the Sec
Q1 2020 Corcept Therapeutics Inc Earnings Call
Intersect ENT®, Inc. (Nasdaq: XENT), a company dedicated to transforming care for patients with ear, nose and throat conditions, today announced that
Is (CORT) Outperforming Other Medical Stocks This Year?
The best biotech companies to invest in tend to have a commonality: a strong streak of earnings growth.
Final earnings conference call transcript of Corcept Therapeutics Inc. - CORT stock
Joseph Belanoff has been the CEO of Corcept Therapeutics Incorporated (NASDAQ:CORT) since 1999. This report will...
Corcept Therapeutics Incorporated (CORT), a commercial-stage company engaged in the discovery and development of drugs to treat severe metabolic, oncologic and psychiatric disorders by modulating the

6 Stocks John Hussman Continues to Buy

05:16pm, Wednesday, 13'th May 2020
AT&T; makes the list Continue reading...

6 Stocks John Hussman Continues to Buy

12:00am, Wednesday, 13'th May 2020
Corcept Therapeutics Inc. (NASDAQ: CORT) continues to make its investors happy. The Menlo Park, Calif., biotech company beat earnings estimates in its first-quarter report last week. While the effe
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE